In the treatment of type 2 diabetes, alpha-glucosidase inhibitors (AGIs; including acarbose, miglitol, voglibose) were recommend by guidelines for glucose control in type 2 diabetes. This evidence concerns the gene GAA and type 2 diabetes mellitus.